Divis Laboratories News: Read Latest News & Live Updates on Divis Laboratories, Photos, Videos at CNBCTV18.com

homeDivis Laboratories News

Divis Laboratories NEWS

All

market | Apr 25, 2024 1:12 PM IST
Divi's Laboratories to expand capacity at manufacturing facility with investment of ₹650 crore to ₹700 crore
business | Nov 16, 2023 11:37 AM IST
Divi's Laboratories gets GST demand notice of ₹164 crore
earnings | Nov 6, 2023 12:41 PM IST
Divi's Laboratories Q2 Results: Management says demand remains stable despite pricing pressure
earnings | Aug 14, 2023 1:06 PM IST
Divi's Labs Q1 Results: Management sees multiple growth prospects in next three years, price pressure stabilising
market | Jun 21, 2023 10:28 AM IST
Divi's Laboratories gets second bearish call in two days - BoFA Securities now sees 11% downside
market | Jun 20, 2023 4:00 PM IST
This analyst sees nearly 27% downside on Divi's Laboratories over concerns on its custom synthesis segment
earnings | May 20, 2023 4:45 PM IST
Divi's Labs Q4 results: Net profit plunges 64% to Rs 321 crore, misses estimates
business | May 19, 2023 12:54 PM IST
Divis Labs Earnings Preview: Sequential recovery eyed led by custom synthesis, heart failure drug
healthcare | Apr 12, 2023 3:48 PM IST
Pharma companies expected to report stable performance for Jan-March quarter
market | Feb 6, 2023 8:50 AM IST
Divi's Laboratories faces price target cuts after lowest ever operating margin
earnings | Feb 3, 2023 1:35 PM IST
Divi's Labs Q3 Result: Multi-quarter low margin drags shares to their worst drop in six years
business | Jan 13, 2023 6:30 AM IST
The underperformers of 2022 - Gland Pharma, Divi's Lab see no respite in the new year either
photos | Jan 12, 2023 4:20 PM IST
Paytm, Divi's Laboratories, SBI Life and more: Key stocks that moved the most on January 12
market | Dec 2, 2022 12:03 PM IST
Morgan Stanley cites these factors why Divi's can underperform its peers
market | Nov 30, 2022 1:39 PM IST
Here’s why foreign investors are looking for investments in Indian API business

Divis Laboratories NEWS

Divi's Laboratories to expand capacity at manufacturing facility with investment of ₹650 crore to ₹700 crore

Divi's Laboratories gets GST demand notice of ₹164 crore

Divi's Laboratories Q2 Results: Management says demand remains stable despite pricing pressure

Divi's Labs Q1 Results: Management sees multiple growth prospects in next three years, price pressure stabilising

Divi's Laboratories gets second bearish call in two days - BoFA Securities now sees 11% downside

This analyst sees nearly 27% downside on Divi's Laboratories over concerns on its custom synthesis segment

Divi's Labs Q4 results: Net profit plunges 64% to Rs 321 crore, misses estimates

Divis Labs Earnings Preview: Sequential recovery eyed led by custom synthesis, heart failure drug

Pharma companies expected to report stable performance for Jan-March quarter

Divi's Laboratories faces price target cuts after lowest ever operating margin

Divi's Labs Q3 Result: Multi-quarter low margin drags shares to their worst drop in six years

The underperformers of 2022 - Gland Pharma, Divi's Lab see no respite in the new year either

Paytm, Divi's Laboratories, SBI Life and more: Key stocks that moved the most on January 12

Morgan Stanley cites these factors why Divi's can underperform its peers

Here’s why foreign investors are looking for investments in Indian API business